SweetValueLab
Write for us

Medtronic Plc — Wall Street Analyst Estimates & Price Targets

MDT
NYSEHealthcareMedical - DevicesCIK 0001613103medtronic.comAbout MDT
Last close · Oct 16, 202694.75−0.70 (−0.73%)
Market cap$121.2B

9 firms' latest targets, last 90 days: median $99.00 ($92.00–$115.00), 4% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$80.0$100$120NovJan 2026MarMayJulSep2025-10-31 · Bernstein: $98.02025-11-19 · Bernstein: $1112025-11-19 · Leerink Partners: $1202025-11-19 · Jefferies: $1102025-11-19 · Goldman Sachs: $1112025-11-20 · Barclays: $1112025-12-16 · Baird: $1032025-12-18 · Truist: $1072026-01-08 · Barclays: $1162026-01-09 · Bernstein: $1122026-01-30 · Wells Fargo: $1142026-02-04 · UBS: $1042026-02-09 · Needham: $1212026-02-18 · Baird: $1002026-02-18 · Barclays: $1182026-03-10 · Leerink Partners: $1192026-03-10 · Needham: $1202026-04-09 · Evercore ISI: $1062026-04-13 · Mizuho Securities: $1202026-04-15 · Truist: $95.02026-04-23 · Jefferies: $95.02026-05-21 · Goldman Sachs: $84.02026-06-03 · BTIG: $90.02026-06-03 · Stifel: $80.02026-06-03 · Needham: $1012026-06-03 · Mizuho Securities: $1002026-06-04 · Truist: $86.02026-06-04 · Bernstein: $97.02026-06-04 · Baird: $85.02026-06-04 · UBS: $85.02026-06-04 · Jefferies: $88.02026-06-05 · Goldman Sachs: $83.02026-06-16 · Piper Sandler: $85.02026-07-06 · Evercore ISI: $1052026-07-13 · BTIG: $91.02026-07-28 · UBS: $1002026-08-27 · Needham: $1142026-09-01 · BTIG: $1002026-09-02 · Mizuho Securities: $1152026-09-02 · Stifel: $95.02026-09-02 · Wells Fargo: $1042026-09-02 · Truist: $99.02026-09-03 · Deutsche Bank: $92.02026-09-03 · UBS: $1102026-10-06 · Barclays: $95.02026-10-12 · BTIG: $99.0
$80.0$100$120NovFebMayAug

Each firm's latest target

last 90 days · 9 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-12BTIG$99.00$100.00▼ 1%+7%+4%
2026-10-06Barclays$95.00$118.00▼ 19%+9%+0%
2026-09-03Deutsche Bank$92.00——+1%-3%
2026-09-03UBS$110.00$100.00▲ 10%+19%+16%
2026-09-02Mizuho Securities$115.00$100.00▲ 15%+25%+21%
2026-09-02Stifel$95.00$80.00▲ 19%+3%+0%
2026-09-02Wells Fargo$104.00$114.00▼ 9%+13%+10%
2026-09-02Truist$99.00$86.00▲ 15%+8%+4%
2026-08-27Needham$114.00$101.00▲ 13%+24%+20%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2024reported$32.4B+4%$2.76-2%est. $33.0B-2%est. $3.2810
2025reported$33.5B+4%$3.61+31%est. $33.5B+0%est. $5.4620
2026reported$36.4B+8%$3.73+3%est. $36.1B+1%est. $5.5211
2027$39.0B+7%$5.98+8%$38.5B–$39.2B$5.97–$6.0021
2028$40.3B+3%$6.40+7%$36.9B–$41.0B$6.28–$6.5420
2029$42.1B+5%$6.91+8%$38.7B–$43.6B$6.06–$7.3915
2030$44.7B+6%$7.49+8%$42.0B–$45.6B$6.89–$7.688
2031$46.0B+3%$8.09+8%$43.2B–$46.9B$7.44–$8.296
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.